Neurobite
Technologies
Pioneering a Sustainable and Effective Future in Neurorehabilitation
EMPOWERING NEURO RECOVERY
What we do
NEUROBITE Technologies is a spin-out from the University of Glasgow that focuses on developing dissolvable medical devices to treat neurological conditions, such as stroke, Parkinson’s Disease, etc.
The problem
Stroke recovery is a journey, one that millions embark upon each year. The road can be fraught with uncertainty, and the treatment landscape can often be overwhelming. Patients and healthcare providers alike face critical challenges
Fear & Apprehension
The thought of implantable devices can be daunting for many post-stroke patients.
Navigating Treatment Options
Understanding and choosing the right treatment can be a maze for those recovering from a stroke.
Surgical Concerns
The potential for multiple surgeries and scarring are real concerns for clinicians.
Environmental Impact
The need for sustainable, eco-friendly medical technology has never been greater.
Share Your Insights
Are you a post-stroke patient, clinician, healthcare provider, or part of a neurotech company?
We invite you to join us in shaping the future of stroke treatment. Participate in our survey, share your insights, and be a part of this revolutionary project.
Our Vision
We aim to revolutionise post-stroke treatment by developing a safe and effective implantable biodegradable neural probe. This approach overcomes the limitations of conventional rigid electronics in existing neural probes by utilising biodegradable materials that reduce the risk of foreign body response and chronic glial scarring. With the ability to simultaneously stimulate and record neural activity in stroke-affected brain regions, our probe paves the way for a new era in stroke treatment.
Brain Implantable Transient Electronics (BITE) probes may help record and stimulate affected areas, thereby promoting new connections and monitoring treatment efficacy in a more personalised manner, tailored to each patient
Our Journey
This project stems from extensive research and a deep understanding of the needs of post-stroke patients, clinicians, and healthcare providers. Our goal is to enhance treatment experiences, reduce surgical interventions, and make a positive environmental impact.
In 2017, the Stroke Alliance for Europe reported 1.12 million stroke incidents in the EU, costing an estimated €45 bn to the EU economy. The stroke care sector faces challenges such as a lack of personalised and intensive post-stroke rehabilitation, this is where Neurobite probes will come into play by delivering tailored and effective neuromodulation to work hand-in-hand with conventional rehabilitation and improving patient outcomes.
EMPOWERING NEURO RECOVERY
Our Impact Areas
Empowering PATIENTS
Informed Choices
We are committed to bridging knowledge gaps, ensuring that patients can make informed decisions about their treatment.
Reduced Fears
Our technology is designed to be less invasive, addressing common fears associated with implantable devices.
SUPPORTING CLINICIANS
Enhanced Treatment
Clinicians can look forward to reduced surgeries and scarring, promoting better patient outcomes.
AI-Enabled Monitoring
Advanced AI technology will help to facilitate improved monitoring and treatment adjustments for patients.
ADVANCING SUSTAINABILITY
Eco-Friendly Innovation
The biodegradable nature of our probes is a step forward in reducing medical waste and promoting sustainability.
Industry Collaboration
We aim to collaborate with specialized neurotech companies, fostering a shared commitment to eco-conscious innovation.
Empowering PATIENTS
Informed Choices
We are committed to bridging knowledge gaps, ensuring that patients can make informed decisions about their treatment.
Reduced Fears
Our technology is designed to be less invasive, addressing common fears associated with implantable devices.
SUPPORTING CLINICIANS
Enhanced Treatment
Clinicians can look forward to reduced surgeries and scarring, promoting better patient outcomes.
AI-Enabled Monitoring
Advanced AI technology will help to facilitate improved monitoring and treatment adjustments for patients.
ADVANCING SUSTAINABILITY
Eco-Friendly Innovation
The biodegradable nature of our probes is a step forward in reducing medical waste and promoting sustainability.
Industry Collaboration
We aim to collaborate with specialized neurotech companies, fostering a shared commitment to eco-conscious innovation.
STAY UPDATED
NEWS & BLOG
mEET OUR TEAM
Maria Cerezo Sanchez
CEO and Co-Founder
Eve McGlynn
Bioelectronics Advisor
Hadi Heidari
Co-founder and Chief Scientific Advisor
Bhavani Yalagala
Lead Engineer
Danial Kiamarsi
Clinical Scientist
Let’s Talk
Our team is eager to collaborate and make a positive impact in the field of neurology. Feel free to use the contact form below or reach out directly via email or phone. We look forward to hearing from you.